147 related articles for article (PubMed ID: 31090152)
1. Canine pyoderma gangrenosum with recurring skin lesions of unknown origin and splenic involvement.
Kang JH; Yoon JH; Kim YB; Hwang CY
Vet Dermatol; 2019 Aug; 30(4):359-e105. PubMed ID: 31090152
[TBL] [Abstract][Full Text] [Related]
2. Canine pyoderma gangrenosum: a case series of two dogs.
Simpson DL; Burton GG; Hambrook LE
Vet Dermatol; 2013 Oct; 24(5):552-e132. PubMed ID: 23931071
[TBL] [Abstract][Full Text] [Related]
3. Neutrophilic dermatosis resembling pyoderma gangrenosum in a dog with polyarthritis.
Bardagí M; Lloret A; Fondati A; Ferrer L
J Small Anim Pract; 2007 Apr; 48(4):229-32. PubMed ID: 17381769
[TBL] [Abstract][Full Text] [Related]
4. UK Dermatology Clinical Trials Network's STOP GAP trial (a multicentre trial of prednisolone versus ciclosporin for pyoderma gangrenosum): protocol for a randomised controlled trial.
Craig FF; Thomas KS; Mitchell EJ; Williams HC; Norrie J; Mason JM; Ormerod AD;
Trials; 2012 Apr; 13():51. PubMed ID: 22540770
[TBL] [Abstract][Full Text] [Related]
5. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
[TBL] [Abstract][Full Text] [Related]
6. Periungual lesions in pyoderma gangrenosum.
Reich A; Maj J; Cisło M; Szepietowski JC
Clin Exp Dermatol; 2009 Jul; 34(5):e81-4. PubMed ID: 19438552
[TBL] [Abstract][Full Text] [Related]
7. Pyoderma gangrenosum after trauma in a dog.
Nagata N; Yuki M; Asahina R; Sakai H; Maeda S
J Vet Med Sci; 2016 Sep; 78(8):1333-7. PubMed ID: 27108868
[TBL] [Abstract][Full Text] [Related]
8. Extensive fatal Pyoderma gangrenosum in a dog after drug exposure.
Schaefer L; Kloß E; Henrich M; Thom N
Tierarztl Prax Ausg K Kleintiere Heimtiere; 2023 Oct; 51(5):361-367. PubMed ID: 37956667
[TBL] [Abstract][Full Text] [Related]
9. Ciclosporin compared with prednisolone therapy for patients with pyoderma gangrenosum: cost-effectiveness analysis of the STOP GAP trial.
Mason JM; Thomas KS; Ormerod AD; Craig FE; Mitchell E; Norrie J; Williams HC;
Br J Dermatol; 2017 Dec; 177(6):1527-1536. PubMed ID: 28391619
[TBL] [Abstract][Full Text] [Related]
10. Bullous pyoderma gangrenosum secondary to underlying multiple myeloma: treated with ciclosporin.
Razmi T M; Muhammed H; Handa S; Malhotra P; Sharma S; Saikia UN; Aggarwal R; Dogra S
Clin Exp Dermatol; 2019 Mar; 44(2):e13-e15. PubMed ID: 30294832
[No Abstract] [Full Text] [Related]
11. Peripheral regional aseptic neutrophilic lymphadenopathy associated with pyoderma gangrenosum.
Al-Niaimi F; Cox NH
Br J Dermatol; 2009 Nov; 161(5):1206-7. PubMed ID: 19678821
[No Abstract] [Full Text] [Related]
12. Pyoderma gangrenosum as initial manifestation of Graves' disease.
Livideanu C; Lipsker D; Paul C; Juillard J; Schubert B
Clin Exp Dermatol; 2006 Sep; 31(5):659-61. PubMed ID: 16780496
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the two most commonly used treatments for pyoderma gangrenosum: results of the STOP GAP randomised controlled trial.
Ormerod AD; Thomas KS; Craig FE; Mitchell E; Greenlaw N; Norrie J; Mason JM; Walton S; Johnston GA; Williams HC;
BMJ; 2015 Jun; 350():h2958. PubMed ID: 26071094
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of SNAP cPL, Spec cPL, VetScan cPL Rapid Test, and Precision PSL Assays for the Diagnosis of Clinical Pancreatitis in Dogs.
Cridge H; MacLeod AG; Pachtinger GE; Mackin AJ; Sullivant AM; Thomason JM; Archer TM; Lunsford KV; Rosenthal K; Wills RW
J Vet Intern Med; 2018 Mar; 32(2):658-664. PubMed ID: 29424454
[TBL] [Abstract][Full Text] [Related]
15. Clinical and histopathological presentation and successful treatment with ciclosporin for canine sarcoidosis: a case report.
Iyori K; Kinoshita M; Imai A; Imanishi I; Shirota K
Vet Dermatol; 2019 Oct; 30(5):438-e136. PubMed ID: 31328338
[TBL] [Abstract][Full Text] [Related]
16. [Pyoderma gangrenosum with aseptic spleen abscess].
Brahimi N; Maubec E; Boccara O; Marinho E; Valeyrie-Allanore L; Lecaille C; Sebban V; Hersent B; Picard-Dahan C; Descamps V; Crickx B
Ann Dermatol Venereol; 2009 Jan; 136(1):46-9. PubMed ID: 19171230
[TBL] [Abstract][Full Text] [Related]
17. Pyoderma gangrenosum: clinical characteristics, associated diseases, and responses to treatment in a retrospective cohort study of 31 patients.
Vacas AS; Torre AC; Bollea-Garlatti ML; Warley F; Galimberti RL
Int J Dermatol; 2017 Apr; 56(4):386-391. PubMed ID: 28295267
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary manifestations of pyoderma gangrenosum: 2 cases and a review of the literature.
Gade M; Studstrup F; Andersen AK; Hilberg O; Fogh C; Bendstrup E
Respir Med; 2015 Apr; 109(4):443-50. PubMed ID: 25622759
[TBL] [Abstract][Full Text] [Related]
19. Pyoderma gangrenosum of the eyelid: report of two cases and review of the literature.
Saito N; Yanagi T; Akiyama M; Lin HY; Kasai S; Fujita Y; Yamane N; Inokuma D; Kase S; Ono K; Minakawa H; Shimizu H
Dermatology; 2010; 221(3):211-5. PubMed ID: 20720387
[TBL] [Abstract][Full Text] [Related]
20. A comparative analysis of canine pancreatic lipase tests for diagnosing pancreatitis in dogs.
Kim JK; Hwang SY; Kim SE; Lee G; Ji S; Kim J; Kim Y
J Vet Sci; 2024 May; 25(3):e48. PubMed ID: 38834516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
